Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial protein translation is the process by which mitochondria synthesize 13 essential proteins from their own DNA, all of which are core subunits of the oxidative phosphorylation system required for ATP production. This process employs specialized mitochondrial ribosomes, unique tRNAs, and dedicated translation factors. Mitochondrial translation is distinct from cytoplasmic translation, sharing more mechanistic similarities with bacterial systems. Dysregulation or genetic defects in this process lead to diverse and often severe diseases, including many childhood metabolic and neuromuscular disorders as well as adult-onset conditions.
Inhibition of mitochondrial translation via ribosomal binding (e.g., by some antibiotics); Modulation of mitochondrial ribosome assembly or function
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial protein translation.